CA2028811C — Aerosol preparation for external use
Assigned to Taisho Pharmaceutical Co Ltd · Expires 1998-12-29 · 27y expired
What this patent protects
Disclosed is an aerosol preparation for external use directed primarily for skin cooling, in the form of a sherbet-shaped foam. The aerosol preparation comprises (B) a concentrate based on water alone or a mixture thereof with a lower alcohol, and (A) as a propellant, a liquefied…
USPTO Abstract
Disclosed is an aerosol preparation for external use directed primarily for skin cooling, in the form of a sherbet-shaped foam. The aerosol preparation comprises (B) a concentrate based on water alone or a mixture thereof with a lower alcohol, and (A) as a propellant, a liquefied petroleum gas or dimethyl ether at a (A):(B) weight ratio of 95:5 to 50:50. The propellant is contained such that the aerosol has a pressure of 2-5 kg/cm2 at 20.degree.C and the sherbet-like foam effectively cools injured skin and lasts long.
Drugs covered by this patent
- Azelex (AZELAIC ACID) · Leo Pharma As
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.